Abnormal motor neuron morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal saccadic eye movement
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of thalamus morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired pectus carinatum
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we evaluated the expression characteristics of miR-15a and its relationship with the expression of acetyl-CoA acyltransferase 1 (<i>ACAA1</i>), acyl-CoA oxidase 1 (<i>ACOX1</i>) and sterol carrier protein 2 (<i>SCP2</i>) by qPCR analysis in Gushi chicken breast muscle at 6, 14, 22, and 30 weeks old, where we performed transfection tests of miR-15a mimics in intramuscular preadipocytes and verified the target gene of miR-15a in chicken fibroblasts (DF1).
|
31434294 |
2019 |
Acquired Polyneuropathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Action Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Adrenocortical carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The mRNA concentrations of SCP2 in two out of three adrenocortical carcinomas were relatively lower than those in other types of tissue.
|
8640304 |
1996 |
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The sterol carrier protein SCP-x/pro-SCP-2 gene has transcriptional activity and regulates the Alzheimer disease gamma-secretase.
|
17485462 |
2007 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
SCP2/SCPx deficiency attenuated atherosclerosis in LS mice by >80% and significantly reduced plasma cholesterol and triglyceride levels.
|
29700117 |
2018 |
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
SCP2/SCPx deficiency attenuated atherosclerosis in LS mice by >80% and significantly reduced plasma cholesterol and triglyceride levels.
|
29700117 |
2018 |
Azoospermia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The triple negative human breast cancer cell lines MDA-MB231 and its sub-progenies SCP2 and SCP25, SUM159PT, SUM149PT, SUM229PE and SUM1315MO2 were treated with 5 ng/ml TGFβ and the protein expression levels were measured by Western blot.
|
22995475 |
2012 |
Childhood Ataxia with Central Nervous System Hypomyelinization
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Cholesterol gallstones
|
0.020 |
Biomarker
|
disease |
BEFREE |
The SCP2 gene was overexpressed in patients with cholesterol gallstone, indicating that SCP2 may be one of the important causes of cholesterol gallstone.
|
15730934 |
2005 |
Cholesterol gallstones
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Moreover, SCP2 was expressed at higher levels in hereditary cholesterol gallstone patients than that of non-hereditary cholesterol gallstone patients.
|
21310066 |
2011 |
Congenital contractural arachnodactyly
|
0.010 |
Biomarker
|
disease |
BEFREE |
Genes MRPS18A, CST1, and SCP2 were identified as candidate genes in the module, which was associated with clinical traits including pathological stage, histological grade, and liver function and which also affected overall survival of CCA patients.
|
31177590 |
2019 |
Congenital pectus carinatum
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we evaluated the expression characteristics of miR-15a and its relationship with the expression of acetyl-CoA acyltransferase 1 (<i>ACAA1</i>), acyl-CoA oxidase 1 (<i>ACOX1</i>) and sterol carrier protein 2 (<i>SCP2</i>) by qPCR analysis in Gushi chicken breast muscle at 6, 14, 22, and 30 weeks old, where we performed transfection tests of miR-15a mimics in intramuscular preadipocytes and verified the target gene of miR-15a in chicken fibroblasts (DF1).
|
31434294 |
2019 |
Connective Tissue Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Type II Natural Killer T Cells that Recognize Sterol Carrier Protein 2 Are Implicated in Vascular Inflammation in the Rat Model of Systemic Connective Tissue Diseases.
|
27863214 |
2017 |
Diabetes Mellitus, Experimental
|
0.200 |
Therapeutic
|
disease |
RGD |
Differential expression of hepatic sterol carrier proteins in the streptozotocin-treated diabetic rat.
|
7628371 |
1995 |
Dyslipidemias
|
0.010 |
Biomarker
|
group |
BEFREE |
These findings suggest targeted inhibition of SCP2 as a potential therapeutic strategy to reduce Western diet-induced dyslipidemia and atherosclerosis.
|
29700117 |
2018 |
Dystonia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia
|
0.310 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia, Diurnal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |
Dystonia, Limb
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.
|
16685654 |
2006 |